Heartburn: all 154 studies

Page 2 of 2. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.

• A Study to Investigate Use Patterns and Safety in Simulated Actual Over-the-counter (OTC) Use of Rabeprazole Sodium for the Treatment of Heartburn SymptomsCompletedNCT01286194
• Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical TrialCompletedNCT01269788Phase 2/3
• Rubber Band Ligation and Mucosectomy for Gastroesophageal Reflux Disease (GERD)TerminatedNCT01199679Not applicable
• Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive HeartburnCompletedNCT01149395Phase 1
• Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.Status unknownNCT01129713Phase 1/2
• The Effect of High PCO2 Solution on Esophageal Acid SensationStatus unknownNCT01128608Not applicable
• Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia.Status unknownNCT01128582Phase 3
• Do Acid Sensing Ion Channels Contribute to Heartburn?CompletedNCT01095133Phase 1
• Effect of Nortriptyline in Cortical Representation of Heartburn in Nonerosive Reflux Disease (NERD) PatientsCompletedNCT01065649Phase 3
• Active Control, Double-blind, Double-dummy, Parallel-group, Randomized Study to Assess the Effect of VECAM 40/300, Administered at Bedtime, vs. Esomeprazole 20 mg, Administered 30-60 Min. Before Dinner, on Daytime and Nighttime GERD SymptomsCompletedNCT01059383Phase 2
• Study to Evaluate the Effect of a Very Low Carbohydrate Diet on Gastroesophageal Reflux DiseaseCompletedNCT00998244Not applicable
• Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation TherapyWithdrawnNCT00928161Not applicable
• Endoscopic Fundoplication Versus Proton Pump Inhibitors for GERD TreatmentTerminatedNCT00857597Phase 3
• Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)CompletedNCT00842387
• ADX10059 as a Monotherapy in Patients With Gastroesophageal Reflux (GERD)CompletedNCT00820079Phase 2
• Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pHCompletedNCT00818870Phase 1
• ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)CompletedNCT00810485Phase 2
• Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.CompletedNCT00786773
• Uric Acid Study in Healthy Male VolunteersCompletedNCT00738842Phase 1
• In Vivo Anatomy, Physiology, Mechanics and Function of the Lower Esophageal SphincterTerminatedNCT00737802
• Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime HeartburnCompletedNCT00701259Phase 3
• Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD.CompletedNCT00674245Phase 2/3
• Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been HealedCompletedNCT00644735Phase 4
• A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive EsophagitisCompletedNCT00641602Phase 4
• Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent Gastrooesophageal Reflux Disease (GERD)CompletedNCT00637845Phase 4
• A Multicenter, Randomized, Double-Blind, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg qd and 40 mg qd to Placebo qd in Patients With Heartburn and Sleep Disturbances Associated With Gastroesophageal Reflux Disease (GERD)CompletedNCT00628342Phase 4
• A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using PatientsCompletedNCT00625274Phase 4
• Confocal Laser Microscopy in Non Erosive Reflux DiseaseCompletedNCT00588939
• Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO CapsuleCompletedNCT00579410
• Demographics and Findings of Upper Endoscopy PatientsTerminatedNCT00576992
• Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.CompletedNCT00553449Phase 3
• What is the Predictive Value of the Reflux Impact ScaleTerminatedNCT00536328
• Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERDCompletedNCT00524355
• Esomeprazole And Symptomatic Response In Patients With Or Without An Elevated Risk For Non-Steroidal Anti-Inflammatory Drug (NSAID)-Associated GI DamageCompletedNCT00524329
• Assessment of Gastro-esophageal Reflux Using Endo-Flip vs BravoCompletedNCT00481949
• Esomeprazole and Gastric Emptying of BeerCompletedNCT00472550Phase 4
• A Comparison of Factors of Symptoms Generation and Evaluation of Role of Biofeedback in Patients With Different Types of Functional Esophageal Disorders (Functional Heartburn and Functional Chest Pain)Status unknownNCT00471796Not applicable
• Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive EsophagitisCompletedNCT00471094Phase 2
• Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERDCompletedNCT00410592Phase 4
• Efficacy/Safety of Lansoprazole in Patients With Frequent HeartburnCompletedNCT00390390Phase 3
• Efficacy/Safety of Lansoprazole in Patients With Frequent HeartburnCompletedNCT00389948Phase 3
• PPI Sequencing StudyCompletedNCT00384592Phase 4
• Efficacy and Safety of Itopride vs Placebo in HeartburnCompletedNCT00382577Phase 3
• PPI Test in GP PatientsCompletedNCT00318084Phase 4
• Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative EsophagitisSuspendedNCT00282555Phase 2
• Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux DiseaseActive, not recruitingNCT00260572
• HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related DiseaseCompletedNCT00243724Phase 3
• A Study of Rabeprazole and Pantoprazole on Stomach Acid and Esophageal Acid Exposure in Patients With Gastroesophageal Reflux Disease (GERD) and a History of Nighttime HeartburnCompletedNCT00237367Phase 4
• A Study of Efficacy and Safety of "On-demand" Maintenance Therapy With Rabeprazole in Patients With Non-erosive Reflux Disease (NERD)CompletedNCT00236392Phase 3
• A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)CompletedNCT00216489Phase 4
• Acid-Associated Heartburn Symptoms and Dose of EsomeprazoleCompletedNCT00206024Phase 4
• Assessment of the Role of Tegaserod Therapy in the Management of Gastroesophageal Reflux Disease (GERD) Symptoms in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).CompletedNCT00171483Phase 3
• The Effects of Tegaserod on Mechanical Sensitivity of the Esophagus and Stomach in Patients With Heartburn and Dyspepsia.CompletedNCT00171457Phase 3
• A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination With Omeprazole Given Orally in Patients With Symptoms of Symptomatic Gastroesophageal Reflux Disease (sGERD)CompletedNCT00149851Phase 2

← Heartburn overview